NEWSROOM

Women Healthcare

PRISM MarketView Announces the Addition of Verastem to Emerging Women’s Health Index

PRISM MarketView Announces the Addition of Verastem to Emerging Women’s Health Index

New York, N.Y., January 12, 2024 - In concert with Cervical Health Awareness Month, PRISM MarketView has added Verastem, Inc., a biopharmaceutical company focused on the development and commercialization of new medicines for patients combating various types of cancer to its Emerging Women’s Health Index. Some of these cancers include breast, gynecological, colorectal and melanoma. The growing PRISM Emerging Women’s Health Index tracks small and micro-cap stocks that focus on a broad range of...

read more
PRISM MarketView Announces the Addition of Verastem to Emerging Women’s Health Index

PRISM MarketView Launches Emerging Women’s Health Index

Global women’s health market projected to reach $67.07 billion by 2031 Private equity investment in women’s health exceeded $3 billion in 2022 New York, N.Y., January 4, 2024 - PRISM MarketView, a leading provider of unbiased market insight and company news, today announces the launch of its PRISM Emerging Women’s Health Index. The growth of the women’s health market is accelerating with the introduction of next-generation therapeutics and artificial intelligence (AI) powered imaging and...

read more

Contact Us

PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850